Carthami-Semen acupuncture point injection for chronic daily headache: A pilot, randomised, double-blind, controlled trial

Complementary Therapies in Medicine

Volumn 19, Issue SUPPL. 1, 2011, Pages

  Park, Jung Mi ^a   Park, Seong Uk ^a   Jung, Woo Sang ^a   Moon, Sang Kwan ^a  

^a Kyung Hee University   (South Korea)

Author keywords

Acupuncture point injection; Carthami Semen (Safflower seed); Chronic daily headache (CDH); Headache Impact Test (HIT)

Indexed keywords

PLACEBO; SAFFLOWER EXTRACT; SODIUM CHLORIDE;

ACUPUNCTURE ANALGESIA; ADULT; ALTERNATIVE MEDICINE; ARTICLE; CHRONIC TENSION HEADACHE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ECCHYMOSIS; FEASIBILITY STUDY; FEMALE; FENGCHI ACUPOINT; HEALTH STATUS; HUMAN; INJECTION SITE PAIN; JIANJING ACUPOINT; MAJOR CLINICAL STUDY; MALE; MIGRAINE; PATIENT SAFETY; PILOT STUDY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; TAIYANG ACUPOINT; THERAPY EFFECT; TREATMENT DURATION;

ACUPUNCTURE POINTS; ACUPUNCTURE THERAPY; ADULT; CARTHAMUS TINCTORIUS; DOUBLE-BLIND METHOD; DRUGS, CHINESE HERBAL; FEMALE; HEADACHE DISORDERS; HEALTH STATUS; HUMANS; INJECTIONS; MALE; MIDDLE AGED; PHYTOTHERAPY; QUALITY OF LIFE; SEEDS; TREATMENT OUTCOME;

EID: 78650679934     PISSN: 09652299     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ctim.2010.09.004     Document Type: Article

References (31)

1. Silberstein S.D., Lipton R.B., Sliwinski M. Classification of daily and near-daily headaches: field trial of revised IHS criteria. Neurology 1996, 47:871-875.
2. Scher A.I., Stewart W.F., Liberman J., Lipton R.B. Prevalence of frequent headache in a population sample. Headache 1998, 38:497-506.
3. Castillo J., Muñoz P., Guitera V., Pascual J. Epidemiology of chronic daily headache in the general population. Headache 1999, 39:190-196.
4. Lanteri-Minet M., Auray J.P., Ei Hasnaoui A., Dartigues J.F., Duru G., Henry P., et al. Prevalence and description of chronic daily headache in the general population in France. Pain 2003, 102:143-149.
5. Saper J.R. Daily chronic headache. Neurol Clin 1990, 8:891-901.
6. Bigal M.E., Rapoport A.M., Lipton R.B., Tepper S.J., Sheftell F.D. Assessment of migraine disability using the migraine disability assessment (MIDAS) questionnaire: a comparison of chronic migraine with episodic migraine. Headache 2003, 43:336-342.
7. Duru G., Auray J.P., Gaudin A.F., Dartigues J.F., Henry P., Lantéri-Minet M., et al. Impact of headache on quality of life in a general population survey in France (GRIM2000 Study). Headache 2004, 44:571-580.
8. Meletiche D.M., Lofland J.H., Young W.B. Quality-of life differences between patients with episodic and transformed migraine. Headache 2001, 41:573-578.
9. Sandrini G., Manzoni G.C., Zanferrari C., Nappi G. An epidemiological approach to the nosography of chronic daily headache. Cephalalgia 1993, 13:72-77.
10. Konno S., Meyer J.S., Margishvilli G.M., Rauch R.A., Haque A. Transformed migraine is a cause of chronic daily headache. Headache 1999, 39:95-100.
11. Mathew N.T., Stubits E., Nigam M.R. Transformation of episodic migraine into daily headache: analysis of factors. Headache 1982, 22:66-68.
12. Coeytaux R.R., Kaufman J.S., Kaptchuk T.J., Chen W., Miller W.C., Callahan L.F., et al. A randomized, controlled trial of acupuncture for chronic daily headache. Headache 2005, 45:1113-1123.
13. Linde K., Streng A., Jürgens S., Hoppe A., Brinkhaus B., Witt C., et al. Acupuncture for patients with migraine: a randomized controlled trial. JAMA 2005, 293:2118-2125.
14. Diener H.C., Kronfeld K., Boewing G., Lungenhausen M., Maier C., Molsberger A., et al. Efficacy of acupuncture for the prophylaxis of migraine: a multicentre randomised controlled clinical trial. Lancet Neurol 2006, 5:310-316. GERAC Migraine Study Group.
15. Melchart D., Streng A., Hoppe A., Brinkhaus B., Witt C., Wagenpfeil S., et al. Acupuncture in patients with tension-type headache: randomised controlled trial. BMJ 2005, 331:376-382.
16. Streng A., Linde K., Hoppe A., Pfaffenrath V., Hammes M., Wagenpfeil S., et al. Effectiveness and tolerability of acupuncture compared with metoprolol in migraine prophylaxis. Headache 2006, 46:1492-1502.
17. Ahn Y.S., Wei T.S., Cho M.R., Chae W.S., Yun Y.C. Effects of aqua-acupuncture of Carthami Flos (GV 15) on the changes of cerebral hemodynamics in rats. J Korean Acupunct Moxibustion Soc 2002, 19:92-111.
18. Lee H.T., Lee H.I. Effect of Cathami Flos aqua-acupuncture on the arthritis induced by injecting Freund's complete adjuvant. J East-West Med 1998, 23:6-20.
19. Kim D.H., Lee K.S., Song B.G. A study on the analgesic and anticoagulative effects of Pericae Semen and Carthami Flos of aqua-acupuncture. J Orient Gynecol 2000, 13:60-73.
20. Lee G.M., Yeom S.C., Kim D.H., Ryu S.W., Kim D.J., Cho N.G., et al. A clinical study of Carthmi-Flos herbal acupuncture treatment on cervical disc herniation patients. J Korean Acupunct Moxibustion Soc 2006, 23:21-35.
21. Yoon M.Y., Cho N.G., Hur T.Y., Cho E.H., Lee O.J., Kim K.S. Clinical study on effect of Carthmi-Flos herbal acupuncture therapy on osteoarthritis in knee joint. J Korean Acupunct Moxibustion Soc 2002, 19:189-200.
22. Yoon M.Y., Cho N.G., Hur T.Y., Cho E.H., Lee O.J., Kim K.S., et al. Clinical study on effect of Carthmi-Flos herbal acupuncture therapy to low back pain patient. J Korean Acupunct Moxibustion Soc 2002, 19:216-229.
23. Bayliss M.S., Batenhorst A.S. The HIT-6TM a user's guide 2002, Quality Metric Incorporated, Lincoln, RI.
24. Dodick D.W., Mauskop A., Elkind A.H., DeGryse R., Brin M.F., Silberstein S.D. Botulinum toxin type a for the prophylaxis of chronic daily headache - subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo controlled study. Headache 2005, 45:315-324.
25. Mathew N.T., Frishberg B.M., Gawel M., Dimitrova R., Gibson J., Turkel C. Botulinum toxin type A (BOTOX) for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo controlled trial. Headache 2005, 45:293-307.
26. Kosinski M., Bayliss M.S., Bjorner J.B., Ware J.E., Garber W.H., Batenhorst A., et al. A six-item short-form survey for measuring headache impact: the HIT-6TM. Qual Life Res 2003, 12:963-974.
27. Ware J.E., Kosinski M., Bjorner J.B., Bayliss M.S., Batenhorst A., Dahlöf C.G., et al. Applications of computerized adaptive testing (CAT) to the assessment of headache impact. Qual Life Res 2003, 12:935-952.
28. Backonja M., Beydoun A., Edwards K.R., Schwartz S.L., Fonseca V., Hes M., et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA 1998, 280:1831-1836.
29. Rowbotham M., Harden N., Stacey B., Berstein P., Magnus-Miller L. Gabapentin for the treatment of post-herpetic neuralgia: a randomized controlled trial. JAMA 1998, 280:1837-1842.
30. Mathew N.T., Rapoport A., Saper J., Magnus L., Klapper J., Ramadan N., et al. Efficacy of gabapentin in migraine prophylaxis. Headache 2001, 41:119-128.
31. Spira P.J., Beran R.G. Gabapentin in the prophylaxis of chronic daily headache: a randomized, placebo-controlled study. Neurology 2003, 61(12):1753-1759. Australian Gabapentin Chronic Daily Headache Group.